UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

Nature reviews cardiology, 2020-12, Vol.17 (12), p.761-772

2020

Link zum Volltext

Verfügbarkeit prüfen

A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes

Spine (Philadelphia, Pa. 1976), 2022-04, Vol.47 (7), p.515

2022

Link zum Volltext

Verfügbarkeit prüfen

Traumatic Transradial Forearm Amputation Temporized With Extracorporeal Membrane Oxygenation: A Brief Report

Military medicine, 2024-01, Vol.189 (1-2), p.e27-e33

2024

Link zum Volltext

Verfügbarkeit prüfen

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497

2012

Link zum Volltext

Verfügbarkeit prüfen

Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

Journal of bone and joint surgery. American volume, 2022-05, Vol.104 (10), p.864

2022

Link zum Volltext

Verfügbarkeit prüfen

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

The lancet. Diabetes & endocrinology, 2014-02, Vol.2 (2), p.116-124

2014

Link zum Volltext

Verfügbarkeit prüfen

Controversies in Spine Surgery: Is i-Factor Superior to Bone Morphogenic Protein for Achieving Spine Fusion?

Clinical spine surgery, 2023-07, Vol.36 (6), p.224

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis

The lancet. Diabetes & endocrinology, 2015-09, Vol.3 (9), p.697-703

2015

Link zum Volltext

Verfügbarkeit prüfen

Increasing Physical Activity in People With Type 2 Diabetes

Diabetes care, 2003-04, Vol.26 (4), p.1186-1192

2003

Link zum Volltext

Verfügbarkeit prüfen

Promoting and maintaining physical activity in people with type 2 diabetes

American journal of preventive medicine, 2004-11, Vol.27 (4), p.289-296

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial

Clinical endocrinology (Oxford), 2006-07, Vol.65 (1), p.40-44

2006

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic delay in monogenic disease: A scoping review

Genetics in medicine, 2024-04, Vol.26 (4), p.101074, Article 101074

2024

Link zum Volltext

Verfügbarkeit prüfen

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of Nine Societies and by Invited Experts)

International journal of behavioral medicine, 2012-12, Vol.19 (4), p.403-488

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage Race

Diabetes care, 2020-05, Vol.43 (5), p.1142-1145

2020

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and atherogenesis

Heart (British Cardiac Society), 2004-03, Vol.90 (3), p.336-340

Fisher, Miles

2004

Link zum Volltext

Verfügbarkeit prüfen

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293

2013

Link zum Volltext

Verfügbarkeit prüfen

Beryllium disease among construction trade workers at department of Energy nuclear sites

American journal of industrial medicine, 2013-10, Vol.56 (10), p.1125-1136

2013

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and myocardial infarction: a time to act or a time to wait?

Diabetic medicine, 1998-04, Vol.15 (4), p.275-275

Miles Fisher, B.

1998

Link zum Volltext

Verfügbarkeit prüfen

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.448-452

2018

Link zum Volltext

Verfügbarkeit prüfen

Insulin-induced hypoglycemia induces a rise in C-reactive protein

Diabetes care, 2000-06, Vol.23 (6), p.861-862

2000

Link zum Volltext

Verfügbarkeit prüfen

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Türk Kardiyoloji Derneği arşivi, 2012-10, Vol.40 Suppl 3, p.1-76

2012

Link zum Volltext

Verfügbarkeit prüfen

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European heart journal, 2016-08, Vol.37 (29), p.2315-2381

2016

Link zum Volltext

Verfügbarkeit prüfen

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

European heart journal, 2012-07, Vol.33 (13), p.1635-1701

2012

Link zum Volltext

Verfügbarkeit prüfen

Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach

Diabetes care, 1991-11, Vol.14 (11), p.949

1991

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and myocardial infarction

Baillière's best practice & research. Clinical endocrinology & metabolism, 1999-07, Vol.13 (2), p.331-343

Fisher, Miles

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe British Journal Of Diabetes & Vascular Disease

ThemaRisk Factors

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(135)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes

Traumatic Transradial Forearm Amputation Temporized With Extracorporeal Membrane Oxygenation: A Brief Report

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

Controversies in Spine Surgery: Is i-Factor Superior to Bone Morphogenic Protein for Achieving Spine Fusion?

Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis

Increasing Physical Activity in People With Type 2 Diabetes

Promoting and maintaining physical activity in people with type 2 diabetes

Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial

Diagnostic delay in monogenic disease: A scoping review

Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage Race

Diabetes and atherogenesis

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Beryllium disease among construction trade workers at department of Energy nuclear sites

Diabetes mellitus and myocardial infarction: a time to act or a time to wait?

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

Insulin-induced hypoglycemia induces a rise in C-reactive protein

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach

Diabetes and myocardial infarction

Aktive Filter

Suchergebnisse filtern